Global Anti-Adhesion Products Market to Exceed $435 Million by 2015, According to New Report by Global Industry Analysts, Inc.

Share Article

GIA announces the release of a global report on Anti-Adhesion Products market. The world market for Anti-Adhesion Products is projected to exceed $435 million by the year 2015. The market is mainly driven by increasing surgeon attention towards anti-adhesion products and anticipated launch of new products currently under pre-clinical development.

Anti-Adhesion Products: A Global Strategic Business Report

Post-surgical adhesion formation is one of the most common complications associated with surgery. About 55% to 100% of the patients who had undergone surgery suffer from adhesions and adhesion related disorders (ARD). The intensity of problems created by adhesion depends on factors such as density, location, tenacity and size. Anti-adhesion products help in reducing post-operative adhesions by forming a mechanical obstruction between organs and internal tissues.

US dominate the global market for anti-adhesion products, as stated by the new market research report on Anti-Adhesion Products. The market is primarily driven by the introduction of new and improved products. Several companies are currently focused on development of effective anti-adhesion solutions that exhibit better clinical efficiency and expanded indications. Abdominal/General surgery represents the largest application market.

Innovative products in form of gels, liquids, and more recently in sprayable forms tend to overcome some of the limitations posed by thin film barriers. Following the approval of pipeline products, currently under clinical trials, the market is expected to report strong growth in the near term. Besides this, improving awareness and interest levels among surgeons is also expected to catalyze the existing competition.

Key players profiled in the study include Angiotech Pharmaceuticals, Inc., Anika Therapeutics, Inc, Baxter International, Inc., Genzyme Corporation, Covidien, Ethicon, Fidia Farmaceutici, S.P.A, FzioMed, Inc., Integra LifeSciences Corporation, LifeCell Corporation, MAST Biosurgery AG, and Synthemed, Inc.

The report titled "Anti-Adhesion Products: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of market trends, competitive scenario, technological overview, product introductions/innovations, and recent industry activity. The study analyzes market data and analytics in terms of value sales for regions including The United States, Europe, and Rest of World by the following surgical procedures - General/Abdominal Surgery, Pelvic/Gynecological Surgery, and Others.

For more details about this comprehensive market research report, please visit - http://www.strategyr.com/Anti_Adhesion_Products_Market_Report.asp

About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a reputed publisher of off-the-shelf market research. Founded in 1987, the company is globally recognized as one of the world's largest market research publishers. The company employs over 800 people worldwide and publishes more than 1100 full-scale research reports each year. Additionally, the company also offers thousands of smaller research products including company reports, market trend reports, and industry reports encompassing all major industries worldwide.

Global Industry Analysts, Inc.
Telephone 408-528-9966
Fax 408-528-9977
Web Site http://www.StrategyR.com/

###

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Public Relations
Visit website